The Rate and Risk Factors for Hospital Re-Admissions Among Neonates with Jaundice at a Tertiary Care Center Experience

Background: Neonates with jaundice discharged early require reliable post-discharge surveillance for neonatal jaundice. A dedicated jaundice clinic can support outpatient monitoring and timely readmission when phototherapy is needed. Risk-based follow-up may reduce unnecessary admissions while protecting infants at higher risk of severe hyperbilirubinemia.

Objectives: To measure the rate of hospital readmission for phototherapy among newborns followed in a dedicated jaundice clinic, to describe the main clinical and laboratory risk factors among readmitted infants, and to evaluate bilirubin trends and treatment needs after readmission.

Methods: This retrospective observational study was conducted at King Abdullah Specialized Children’s Hospital (KASCH), King Abdulaziz Medical City, Jeddah, Saudi Arabia. The population comprised newborns seen in the neonatal jaundice clinic after discharge from their birth hospitalization, with a focus on infants subsequently readmitted for inpatient phototherapy. Data collected included demographics, bilirubin values, feeding pattern, hemolytic risk factors, clinic visits, and readmission characteristics. The denominator was 1,230 infants followed in the jaundice clinic over one year.

Results: Of approximately 1,230 newborns followed, 59 were readmitted for further management. Mean gestational age was 38.26 weeks and mean birth weight was 3,026 g. The median number of clinic visits before readmission was 1 (IQR 1–2). Mean bilirubin was 175 μmol/L at discharge and 293 μmol/L at readmission.

Discussion: A dedicated jaundice clinic can safely support post-discharge monitoring for most newborns at risk of neonatal jaundice. The readmission rate in this study was lower than that reported in another study (4.8% vs. 7.6%), suggesting the potential effectiveness of structured follow-up in a dedicated neonatal jaundice clinic. The high proportion of infants with risk factors reinforces the importance of risk-based surveillance and timely bilirubin reassessment. Treatment needs varied, with a substantial subset requiring double or intensive phototherapy.

Conclusion: Among newborns followed in a dedicated jaundice clinic, readmission for phototherapy was uncommon. Most readmitted infants had identifiable clinical or laboratory risk factors. Structured post-discharge surveillance supports timely treatment while allowing most infants to remain at home with their mothers.